Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 02/07/2008
SPC Urografin

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/07/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
Date of revision of text on the SPC:   01-May-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 4.2 - References to Schering have been removed and replaced with 'the licence holder'.
Updated on 06/06/2008 and displayed until 02/07/2008
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   01-May-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


All updates are due to change of ownership, from Schering Healthcare Ltd to Bayer Plc effective from 1 May

Section 7: MAH now Bayer plc
Section 8: Licence numbers are now PL 00010/ 0568, 0569 & 0570
Section 9: Date of first authorisation is now 1 May 2008
Section 10: Revision date is now 1 May 2008 
Updated on 20/05/2005 and displayed until 06/06/2008
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
Updated on 24/09/2003 and displayed until 20/05/2005
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 03/06/2003 and displayed until 24/09/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/02/2003 and displayed until 03/06/2003
Reasons for adding or updating:
  • Change from datasheet to SPC
Updated on 02/01/2001 and displayed until 18/02/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 02/01/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  sodium amidotrizoate
  meglumine amidotrizoate